Bolar investor litigation
Executive Summary
Aug. 4 complaint by investor Martin Bergstein alleges firm violated federal securities laws and engaged in fraud and "other misrepresentations." The plaintiff seeks unspecified damages for himself "and all other persons who during the period Aug. 21, 1987 to Aug. 3, 1989 purchased" Bolar stock. In an Aug. 10 statement, firm said the complaint is based on "the alleged failure" to disclose that its ANDA for a generic version of Dyazide "was fraudulent and questionable." Bolar commented that the allegations "are without merit" and said it will "defend the action vigorously".
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.